Form 4: Senseonics Director Acquires Shares as Compensation
Insider Transaction Report
Senseonics Holdings, Inc. Director Edward Fiorentino acquired 34,200 shares of common stock as part of his non-employee director compensation.
Summary
- Director Edward Fiorentino acquired 34,200 shares of Senseonics Holdings, Inc. common stock.
- The transaction occurred on October 1, 2025, at a price of $0.413 per share.
- The total value of the acquired shares is $14,124.60.
- These shares were issued in lieu of quarterly retainer fees, consistent with the company's non-employee director compensation policy.
- Following this transaction, Mr. Fiorentino beneficially owns 1,379,301 shares of common stock.
Sentiment
Score: 7
Explanation: The acquisition of shares by a director, even as part of compensation, generally indicates a positive alignment of interests. It's a routine event but still shows commitment from management.
Positives
- Director Edward Fiorentino increased his direct ownership in Senseonics Holdings, Inc. by acquiring 34,200 shares.
- The acquisition demonstrates alignment of director interests with shareholder interests, as shares were received in lieu of cash compensation.
Future Outlook
The filing does not contain specific forward-looking statements or guidance beyond the details of the reported transaction.
Management Comments
- This common stock was issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.
Industry Context
This insider transaction reflects a standard compensation practice for non-employee directors in the medical device or biotechnology industry, where equity compensation is often used to align director interests with long-term shareholder value. Senseonics Holdings, Inc. operates in the continuous glucose monitoring (CGM) market, a growing segment within medical devices.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Edward Fiorentino granted a Power of Attorney to several individuals, including company officers, to prepare, execute, and submit Forms 3, 4, and 5 on his behalf for Section 16(a) compliance. | 09/12/2025 | Streamlines the process for insider trading reporting, ensuring timely and accurate filings for the director. |
Stakeholder Impact
- Shareholders: Increased director ownership aligns interests, potentially signaling confidence in the company's future.
- Management: The compensation policy ensures directors are compensated with equity, linking their financial incentives to company performance.
Key Dates
| Date | Description |
|---|---|
| 09/12/2025 | Date Power of Attorney was executed by Ed Fiorentino. |
| 10/01/2025 | Date of transaction where common stock was acquired. |
| 10/03/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThis Form 4 reports a routine acquisition of shares by a director as part of their compensation package, not a discretionary market purchase. While it shows alignment of interests, it does not provide new fundamental information to warrant a change in investment recommendation. The transaction is an expected part of corporate governance and compensation practices.
Keywords
Senseonics Holdings, SENS, Edward Fiorentino, Insider Transaction, Director Compensation, Stock Acquisition, SEC Form 4, Biotechnology, Medical Devices
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.